CYTOKINES, CHEMOKINES AND GROWTH FACTORS ASSOCIATED WITH CHRONIC VIRAL HEPATITIS C

Chronic hepatitis C (CHC) represents a significant public health concern. In the majority of cases, the infection progresses to a chronic form, which is characterised by the development of fibrosis and cirrhosis of the liver. A plethora of cytokines and chemokines are generated as a consequence of inflammatory processes within the liver. These can exert a dual effect, both protective and damaging, particularly in relation to the death of hepatocytes and the progression of liver fibrosis. Furthermore, a number of growth factors have been identified as playing a role in the pathogenesis of CHC. The objective of the study was a comprehensive evaluation of a wide range of cytokines, chemokines and growth factors in the blood plasma of patients with CHC at varying stages of liver fibrosis. The study cohort comprised 63 patients diagnosed with CHC, who were divided into three groups according to the stage of liver fibrosis. The control group comprised healthy individuals (n=32). Concentrations of the following cytokines were determined in plasma: Interleukins and some cytokines (IL-1α, IL-1β, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-17A, IL-17-E/IL-25, IL-17F, IL-18, IL-27, IFNα, IFNγ, TNFα, TNFβ); chemokines (CCL2/MCP-1, CCL3/MIP-1α, CCL4/MIP-1β, CCL7/MCP-3, CCL11/Eotaxin, CCL22/MDC, CXCL1/GROα, CXCL8/IL-8, CXCL9/MIG, CXCL10/IP-10, CX3CL1/Fractalkine) and growth factors (EGF, FGF-2, Flt-3L, G-CSF, M-CSF, PDGF-AA, PDGF-AB/BB, TGFα, VEGF-A) by multiplex analysis based on xMAP technology. Nonparametric statistics methods were used for statistical analysis. As a result of the study, increased concentrations of cytokines IL-12 (p40), IL-15, IL-17E/IL-25, IL-27, IFNγ, TNFα, chemokines CXCL9/MIG and CXCL-10/IP-10 and growth factors FGF-2 and M-CSF were found at all stages of liver fibrosis. Elevated concentrations of cytokines IL-1α, IL-1β, IL-2, IL-6, IL-9, IL-10, IL-17F, IFNα, TNFβ, chemokines CCL2/MCP-1, CCL11/Eotaxin, CCL22/MDC and growth factors G-CSF, TGFα, Flt-3L were found in severe liver fibrosis/cirrhosis. Correlation analysis revealed a relationship of high significance between the severity of liver fibrosis and the content of cytokines IL-6, IFNγ, TNFα, IL-7, chemokines CCL2/MCP-1, CCL11/Eotaxin, CXCL9/MIG, CXCL10/IP-10, CXCL1/GROα, growth factors TGFα, PDGF-AA, PDGF-AB/BB. Thus, a certain profile of cytokines characteristic for CHC was revealed, cytokines, chemokines and growth factors significant for liver fibrosis in CHC were found. 

1. Arsentieva N.A., Semenov A.V., Zhebrun D.A., Vasilyeva E.V., Totolian A.A. Role of CXCR3 chemokine receptor and its ligands in certain diseases. Medical Immunology, 2019, Vol. 21, no. 4, pp. 617-632. doi.org/10.15789/1563-0625-2019-4-617-632

2. Arsentieva N.A., Semenov A.V., Lyubimova N.E., Basina V.V., Esaulenko E.V., Kozlov K.V., Zhdanov K.V., Totolyan A.A. Contents cytokines and chemokines in blood plasma of patients with chronic viral hepatitis C. Russian journal of immunology, 2015, Vol. 18, no. 1, pp. 80-89. https://www.elibrary.ru/download/elibrary_23500742_95156075.pdf

3. Arsent'eva N.A., Semenov A.V., Lyubimova N.E., Ostankova Y.V., Elezov D.S., Totolyan A.A., Kudryavtsev I.V., Basina V.V., Esaulenko E.V., Kozlov K.V., Zhdanov K.V. Chemokine receptors CXCR3 and CCR6 and their ligands in the liver and blood of patients with chronic hepatitis C. Bulletin of Experimental Biology and Medicine, 2015, Vol. 160, no. 2, pp. 252-255 https://www.elibrary.ru/item.asp?id=23904497

4. Arsentieva N.A., Semenov A.V., Totolian A.A. The role of cytokine genes polymorphism C virus infection. Russian Journal of Infection and Immunity, 2012, Vol. 2., no. 4, pp. 687-698. doi: 10.15789/2220-7619-2012-4-687-698

5. Basina V.V., Arsentieva N.A., Batsunov O.K., Lyubimova N.E., Semenov A.V., Esaulenko E.V., Totolian A.A. Expression patterns of chemokine receptors CXCR3 and CCR6, and their ligands in peripheral blood of patients with chronic hepatitis C during antiviral therapy using pegylated interferons. Medical Immunology, 2019, Vol. 21, no. 1, pp. 107-120. doi.org/10.15789/1563-0625-2019-1-107-120

6. https://www.who.int/ru/news-room/fact-sheets/detail/hepatitis-c).

7. Zhdanov K.V., Gusev D.A., Chirsky B.C., Sysoev K.A., Yakubovskaya L.A., Shakhianov D.M., Totolyan A.A. Chronic HCV infection and expression of mRNA of CC chemokines and their receptors. Journal of Microbiology, Epidemiology and Immunobiology, 2008, no. 4, pp. 73-77. https://www.elibrary.ru/item.asp?id=11649368

8. Zhdanov K.V., Gussev D.А., Chirskiy V.S., Syssoev К.А., Yakubovskaya L.А., Shakhmanov D.М., Totolian Areg А. Chemokines and their receptors expression in blood and liver tissue in chronic hepatitis C. Medical Immunology, 2007, Vol. 9, no. 4-5, pp. 379-388. doi.org/10.15789/1563-0625-2007-4-5-379-388

9. Ivkova A.N., Ilchenko L.Y., Kushlinsky N.E., Petrenko N.V., Storozhakov G.I. Growth factors in the assessment of liver fibrosis in patients with chronic hepatitis C Experimental and clinical gastroenterology, 2008, no. 5, pp. 42-46.

10. https://www.elibrary.ru/download/elibrary_15238307_37670113.pdf

11. Klyarytskaya I.L., Stilidi E.I. The role of various cytokines in the liver fibrogenesis in chronic viral hepatitis B and C. Crimean Journal of Internal Diseases, 2010, no. 1, pp. 41-45. https://www.elibrary.ru/download/elibrary_21104319_43348672.pdf

12. Klyarytskaya I.L., Stilidi E.I. Serum cytokines as markers of liver fibrosis and predictors of antiviral therapy efficiency in chronic hepatitis C. Crimean Journal of Internal Diseases, 2013, no. 1, pp. 95-100.

13. Korotchayeva Yu.V., Samokhodskaya L.M., Speransky A.I., Kozlovskaya L.V., Gordovskaya M.B., Pavlenko A.V., Mukhin N.A., Tkachuk V.A. Prognostic value of il-6 in blood serum and cytochrome P450 in liver tissue in patients with chronic hepatitis С. Russian Journal of Gastroenterology, Hepatology, Coloproctology, 2008, Vol. 18, no. 2, pp. 42-47. https://www.elibrary.ru/item.asp?id=11630716

14. Maksimova A.A., Shevela E.Ya., Sakhno L.V., Tikhonova M.A., Ostanin A.A., Chernykh E.R. M-CSF and GM-CSF determinate fibromodulatory activity of polarized human macrophages. Medical Immunology, 2022, Vol. 24, no. 5, pp. 931-942 doi.org/10.15789/1563-0625-MCA-2525.

15. Pritulina YUG, Prokopenko SE. Immunological aspects of treatment of chronic hepatitis C. Journal of New Medical Technologies, e-edition. 2021, no. 1, pp. 47-52. doi.org/10.24412/2075-4094-2021-1-1-6.

16. Semenov A.V., Arsentieva N.A., Elezov D.S., Kudryavtsev I.V., Esaulenko E.V., Totolyan A.A. Features of population composition of peripheral blood CXCR3-positive lymphocytes in chronic viral hepatitis C patients. Journal of microbiology, epidemiology and immunobiology, 2013, no. 5, pp. 69-76. https://www.elibrary.ru/item.asp?id=23087828

17. Semenov A.V., Arsentieva N.A., Lubimova N.E., Tulienev S.V., Basina V.V., Esaulenko E.V., Totolyan A.A. The role of cytokines and сhemokines in laboratory diagnostic of chronic viral hepatitis C. Klinicheskaya Laboratornaya Diagnostika, 2015, Vol. 60, no. 8, pp. 45–51. https://www.elibrary.ru/download/elibrary_24157097_78183572.pdf

18. Sysoyev K.A., Tchukhlovin A.B., Totolyan A.A. The diagnostic role of chemokines and their receptors under chronic hepatitis C. Clinical laboratory diagnostics, 2013, no. 2, pp. 23-29. https://www.elibrary.ru/download/elibrary_18923711_40339791.pdf

19. Sysoev K.A., Chukhlovin A.V., Shakhmanov D.M., Zhdanov K.V., Totolian A.A. Cytokines and chemokines in the blood plasma of patients with chronic hepatitis C. Russian Journal of Infection and Immunity, 2013, Vol. 3, no. 1, pp. 49-58. doi: 10.15789/2220-7619-2013-1-49-58

20. - Ahlenstiel G. The Natural Killer Cell Response to HCV Infection. Immune Netw., 2013, Vol. 13, no. 5, pp. 168-176. doi.org/10.4110/in.2013.13.5.168

21. - Ahmad A., Alvarez F. Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. J. Leukoc. Boil., 2004, Vol. 76, no. 4, pp. 743–759. doi.org/10.1189/jlb.0304197

22. - Asselah T., Bièche I., Laurendeau I., Paradis V., Vidaud D., Degott C., Martinot M., Bedossa P., Valla D., Vidaud M., Marcellin P. Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology, 2005, Vol. 129, no. 6, pp. 2064-2075. doi.org/10.1053/j.gastro.2005.09.010.

23. - Bruno C.M., Valenti M., Bertino G., Ardiri A., Amoroso A., Consolo M., Mazzarino C.M., Neri S. Relationship between circulating interleukin-10 and histological features in patients with chronic C hepatitis. Ann. Saudi. Med., 2011, Vol. 31, no. 4, pp. 360-364. doi: 10.4103/0256-4947.83215

24. - Burke M.L., McManus D.P., Ramm G.A., Duke M., Li Y., Jones M.K., Gobert G.N. Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis. PLoS Negl. Trop. Dis., 2010, Vol. 4, no. 2, pp. e598. doi: 10.1371/journal.pntd.0000598.

25. - Butera D., Marukian S., Iwamaye A.E., Hembrador E., Chambers T.J., Di Bisceglie A.M., Charles E.D., Talal A.H., Jacobson I.M., Rice C.M., Dustin L.B. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood., 2005, Vol. 106, no. 4, pp. 1175-1182. doi: 10.1182/blood-2005-01-0126

26. - Casrouge A., Decalf J., Ahloulay M., Lababidi C., Mansour H., Vallet-Pichard A., Mallet V., Mottez E., Mapes J., Fontanet A., Pol S., Albert M.L. Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J. Clin. Invest., 2011, Vol. 121, no. 1, pp. 308-317. doi: 10.1172/JCI40594

27. Corado J., Toro F., Rivera H., Bianco N.E., Deibis L., De Sanctis J.B. Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection. Clin. Exp. Immunol., 1997, Vol. 109, no.3, pp. 451–457. doi: 10.1046/j.1365-2249.1997.4581355.x.

28. - Elia G., Fallahi P. Hepatocellular carcinoma and CXCR3 chemokines: a narrative review. Clin. Ter., 2017, Vol. 168, no. 1, pp. e37-e41. doi: 10.7417/CT.2017.1980

29. - Falasca K., Ucciferri C., Dalessandro M., Zingariello P., Mancino P., Petrarca C., Pizzigallo E., Conti P., Vecchiet J. Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann Clin Lab Sci., 2006, Vol. 36, no. 2, pp. 44-50. PMID: 16682509

30. - Fry T.J., Connick E., Falloon J., Lederman M.M., Liewehr D.J., Spritzler J., Steinberg S.M., Wood L.V., Yarchoan R., Zuckerman J., Landay A., Mackall C.L. A potential role for interleukin-7 in T-cell homeostasis. Blood, 2001, Vol. 97, no. 10, pp. 2983–2990. doi: 10.1182/blood.v97.10.2983

31. - Haskill S., Peace A., Morris J., Sporn S.A., Anisowicz A., Lee S.W., Smith T., Martin G., Ralph P., Sager R. Identification of three related human GRO genes encoding cytokine functions. Proc. Natl. Acad. Sci. USA, 1990, Vol. 87, pp. 7732–7736. doi: 10.1073/pnas.87.19.7732

32. - Johansson S., Talloen W., Tuefferd M., Darling J.M., Scholliers A., Fanning G., Fried M.W., Aerssens J. Plasma levels of growth-related oncogene (CXCL1-3) associated with fibrosis and platelet counts in HCV-infected patients. Aliment. Pharmacol. Ther., 2015, Vol. 42, no. 9, pp. 1111-1121. doi: 10.1111/apt.13389.

33. - Judge C.J., Kostadinova L., Sherman K.E., Butt A.A., Falck-Ytter Y., Funderburg N.T., Landay A.L., Lederman M.M., Sieg S.F., Sandberg J.K., Anthony D.D. CD56bright NK IL-7Rα expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections. J. Leukoc. Biol., 2017, Vol. 102, no. 1, pp. 171-184. doi: 10.1189/jlb.5A1116-456R

34. Keynan Y., Card C.M., McLaren P.J., Dawood M.R., Kasper K., Fowke K.R. The Role of Regulatory T Cells in Chronic and Acute Viral Infections. Clin. Infect. Dis., 2008, Vol. 46, no. 7, pp. 1046–1052. doi: 10.1086/529379

35. - Khan S., Bhargava A., Pathak N., Maudar K.K., Varshney S., Mishra P.K. Circulating Biomarkers and their Possible Role in Pathogenesis of Chronic Hepatitis B and C Viral Infections. Indian J. Clin. Biochem., 2011, Vol. 26, no. 2, pp. 161-168. doi: 10.1007/s12291-010-009

36. - Kocabayoglu P., Lade A., Lee Y.A., Dragomir A.C., Sun X., Fiel M.I., Thung S., Aloman C., Soriano P., Hoshida Y., Friedman S.L. β-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis. J. Hepatol., 2015, Vol. 63, pp. 141–147. doi.org/10.1016/j.jhep.2015.01.036.

37. - Larrubia J.R., Benito-Martínez S., Miquel-Plaza J., Sanz-de-Villalobos E., González-Mateos F., Parra T. Cytokines - their pathogenic and therapeutic role in chronic viral hepatitis. Rev. Esp. Enferm. Dig., 2009, Vol. 101, no. 5, pp. 343-351. doi: 10.4321/s1130-01082009000500006

38. - Lauer G.M., Walker B.D. Hepatitis C virus infection. The New England Journal of Medicine, 2001, Vol. 345, no. 1, pp. 41–52. doi: 10.1056/NEJM200107053450107.

39. - Lee S.H., Miyagi T., Biron C.A. Keeping NK cells in highly regulated antiviral warfare. Trends Immunol., 2007, Vol. 28, no. 6, pp. 252-259. doi: 10.1016/j.it.2007.04.001.

40. - Lottini G., Plicanti E., Lai M., Quaranta P., Pistello M., Freer G.. Canonical fibroblast growth factors in viral infection. Rev. Med. Virol., 2023, Vol. 33, no. 4, pp. e2452. doi: 10.1002/rmv.2452.

41. Minty A., Chalon P., Derocq J.M., Dumont X., Guillemot J.C., Kaghad M. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature, 1993, Vol. 362, no. 6417, pp. 248–250. doi: 10.1038/362248a0.

42. - Moura A.S., Carmo R.A., Teixeira A.L., da Costa Rocha M.O.. Soluble inflammatory markers as predictors of hepatocellular damage and therapeutic response in chronic hepatitis C. Braz. J. Infect. Dis., 2009, Vol. 13, pp. 375-382. doi.org/10.1590/S1413-86702009000500013.

43. - Mourtzikoua A., Alepakia M., Stamoulic M., Pouliakisa A., Sklirisc A., Karakitsos P.Evaluation of serum levels of IL-6, TNF-α, IL-10, IL-2 and IL-4 in patients with chronic hepatitis. Immunologia., 2014, Vol. 33, no. 16, pp. 41-50. doi.org/10.1016/j.inmuno.2014.01.001

44. - Nischalke H.D., Berger C., Luda C., Müller T., Berg T., Coenen M., Krämer B., Körner C., Trebicka J., Grünhage F., Lammert F., Nattermann J., Sauerbruch T., Spengler U. The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patients. J Hepatol., 2012, Vol. 56, no. 4, pp. 758-764. doi: 10.1016/j.jhep.2011.10.019.

45. - Preisser L., Miot C., Le Guillou-Guillemette H., Beaumont E., Foucher E.D., Garo E., Blanchard S., Frémaux I., Croué A., Fouchard I., Lunel-Fabiani F., Boursier J., Roingeard P., Calès P., Delneste Y., Jeannin P. IL-34 and macrophage colony-stimulating factor are overexpressed in hepatitis C virus fibrosis and induce profibrotic macrophages that promote collagen synthesis by hepatic stellate cells. Hepatology, 2014, Vol. 60, no. 6, pp. 1879-1890. doi: 10.1002/hep.27328.

46. - Radkowski M., Grabarczyk P., Kryczka T., Caraballo Cortès K., Kubicka-Russel D., Janiak M., Osuch S., Perlejewski K., Laskus T. Cytokine profile and viral diversity in the early seronegative stage of community-acquired hepatitis C virus (HCV) infection. Sci. Rep., 2023, Vol. 13, no. 1, pp. 20045. doi: 10.1038/s41598-023-47335-x.

47. - Ramadori G., Saile B. Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question. Gastroenterology., 2004, Vol. 127, no. 3, pp. 997–1000. doi: 10.1053/j.gastro.2004.07.041

48. - Rowell D.L., Eckmann L., Dwinell M.B., Carpenter S.P., Raucy J.L., Yang S.K., Kagnoff M.F. Human hepatocytes express an array of proinflammatory cytokines after agonist stimulation or bacterial invasion. Am. J. Physiol., 1997, Vol. 273, pp. 322–332. doi: 10.1152/ajpgi.1997.273.2.G322.

49. - Schwabe R.F., Brenner D.A.. Mechanisms of liver injury: TNF-a-induced liver injury: role of IKK, JNK, ROS pathways. Am. J. Physiol. Gastrointest. Liver Physiol., 2006, Vol. 290, pp. G583-G589. doi.org/10.1152/ajpgi.00422.20054

50. - Shields P.L., Morland C.M., Salmon M., Qin S., Hubscher S.G., Adams D.H. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. Journal of Immunology., 1999, Vol. 163, no. 11, pp. 6236–6243. PMID: 10570316

51. - Shive C.L., Kowal C.M., Desotelle A.F., Nguyen Y., Carbone S., Kostadinova L., Davitkov P., O'Mara M., Reihs A., Siddiqui H., Wilson B.M., Anthony D.D.. Endotoxemia associated with liver disease correlates with systemic inflammation and T-cell exhaustion in hepatitis C virus infection. Cells, 2023, Vol. 12, no. 16, pp. 2034. doi: 10.3390/cells12162034.

52. - Soresi M., Giannitrapani L., D'Antona F., Florena A.M., La Spada E., Terranova A., Cervello M., D'Alessandro N., Montalto G. Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. World J. Gastroenterol., 2006, Vol. 12, no. 16, pp. 2563256-2563258. doi: 10.3748/wjg.v12.i16.2563.

53. - Szabo G., Dolganiuc A. Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection. Immunobiology., 2005, Vol. 210, no. 2–4, pp. 237–247. doi: 10.1016/j.imbio.2005.05.018.

54. - Tan J.T., Dudl E., LeRoy E., Murray R., Sprent J., Weinberg K.I., Surh C.D. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc. Natl. Acad. Sci. USA., 2001; Vol. 98, no. 15, pp. 8732–8737. doi: 10.1073/pnas.161126098.

55. - Tsunematsu H., Tatsumi T., Kohga K., Yamamoto M., Aketa H., Miyagi T., Hosui A., Hiramatsu N., Kanto T., Hayashi N., Takehara T. Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells. Int. J. Cancer., 2012, Vol. 130, no. 2, pp. 356-364. doi: 10.1002/ijc.26003

56. - Vahedi F., Lee A.J., Collins S.E., Chew M.V., Lusty E., Chen B., Dubey A., Richards C.D., Feld J.J., Russell R.S., Mossman K.L., Ashkar A.A. IL-15 and IFN-γ signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signaling. Cytokine., 2019, Vol. 124, e: 154439. doi: 10.1016/j.cyto.2018.06.006.

57. - Wullaert A., van Loo G., Heyninck K., Beyaert R. Hepatic TNF signaling and NF-κB: effects on liver homeostasis and beyond. Endocrine Reviews, 2007, Vol. 28, no. 4, pp. 365-386. doi.org/10.1210/er.2006-0031

58. - Xie Y., Su N., Yang J., Tan Q., Huang S., Jin M., Ni Z., Zhang B., Zhang D., Luo F., Chen H., Sun X., Feng J.Q., Qi H., Chen L. FGF/FGFR signaling in health and disease. Signa.l Transduct. Target. Ther., 2020, Vol. 5, no. 1, pp. 181. doi: 10.1038/s41392-020-00222-7.

59. - Zdanov A. Structural features of the interleukin-10 family of cytokines. Curr. Pharm. Des., 2004, Vol. 10, no. 31, pp. 3873-3884. doi: 10.2174/1381612043382602

60. - Zeremski M., Petrovic L.M., Talal A.H. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J. Viral. Hepat., 2007, Vol. 14, no. 10, pp. 675-687. doi: 10.1111/j.1365-2893.2006.00838.x.